|
gptkbp:instanceOf
|
radiopharmaceutical
|
|
gptkbp:activeIngredient
|
gptkb:Ioflupane_(123I)
|
|
gptkbp:administeredBy
|
intravenous injection
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
2011 (US)
|
|
gptkbp:ATCCode
|
gptkb:V09AB03
|
|
gptkbp:chemicalFormula
|
C18H23FIN2O2
|
|
gptkbp:contraindication
|
pregnancy
hypersensitivity to ioflupane or excipients
|
|
gptkbp:detects
|
dopamine transporter levels
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:halfLife
|
13 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DaTscan
|
|
gptkbp:indication
|
differentiation of Parkinson's disease from other movement disorders
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:license
|
gptkb:GE_Healthcare
|
|
gptkbp:manufacturer
|
gptkb:GE_Healthcare
|
|
gptkbp:notRecommendedFor
|
differentiation of Parkinson's disease from atypical parkinsonian syndromes
|
|
gptkbp:photographed
|
gptkb:SPECT
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:radioisotope
|
gptkb:Iodine-123
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
nausea
dizziness
headache
injection site pain
|
|
gptkbp:storage
|
store below 25°C
|
|
gptkbp:usedFor
|
differentiation of essential tremor from Parkinsonian syndromes
diagnosis of Parkinsonian syndromes
|
|
gptkbp:bfsParent
|
gptkb:idiopathic_Parkinson's_disease
|
|
gptkbp:bfsLayer
|
6
|